Year-End Report 2005

Report this content

Fourth Quarter and Full Year Results 2005

- Net sales amounted to 138.4 MSEK (106.2) in the fourth quarter and to 430.4 MSEK (366.6) for the full year 2005. - Operating profit amounted to –4.7 MSEK (0.6) in the fourth quarter and to –62.9 MSEK (–61.7) for the full year 2005. - The net result for the fourth quarter amounted to 0.4 MSEK (–10.8) and to –39.9 MSEK (–74.7) for the full year 2005. - Earnings per share in the fourth quarter amounted to 0.01 SEK (–0.19) and to –0.57 SEK (–1.29) for the full year 2005. - The cash flow from the current business was positive in the fourth quarter. - In June the business of the American company Argonaut was acquired and the integration has proceeded according to plan during the year. - In October Separtis Holding AG, distributor of many of Biotage’s products in Switzerland, Germany and Austria, was acquired. - The new share issue completed in November was fully subscribed and provided the company approx. 48.3 MSEK before deduction of issue expenses. - In January 2006 exclusive distribution, production and further development rights to Vapourtec’s solvent evaporation system V-10 were acquired. Contact: Jeff Bork, President and CEO Tel: +46 734-22 16 60 Mats-Olof Wallin, CFO Tel: +46 705-93 52 73